Studying caplyta for adults with social anxiety disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether the medication caplyta (lumateperone) helps reduce symptoms of social anxiety disorder compared to a placebo. If it works, it could give people a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with social anxiety disorder.
- Your social anxiety symptoms are at least moderately severe.
- You do not have certain other mental health conditions like schizophrenia or bipolar disorder.
- You are not at immediate risk of suicide.
- You are not currently taking certain other psychiatric medications.
- If you could become pregnant, you agree to use birth control during the study and for 4 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medicine called NTX-1472 to see if it helps people with social anxiety disorder. Participation involves taking the study drug and attending scheduled visits.
This study is testing a computer-based treatment for social anxiety disorder. It may help reduce anxiety in social situations through a structured online program, and it also includes brain imaging (MRI) to see how the treatment affects the brain.
This study tests a new medication (lumateperone) versus a placebo to see if it helps reduce symptoms of major depressive disorder. It is for people with moderate to severe depression who may be looking for a new treatment option.
This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This study tests whether adding lumateperone to an antidepressant helps adults with major depressive disorder (MDD) who haven’t improved enough after trying at least two different antidepressants. It may help reduce depressive symptoms more than antidepressants alone.
Hear when a new Social Anxiety Disorder (SAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.